HB-EGF enhanced CMT93 and HT-29 cell proliferation, while HB-EGF knockdown (KD) by siRNA (si-HB-EGF) slowed down tumor growth (Fig. 1E, F). This evidence concerns the gene HBEGF and neoplasm.